CD48 is an allergen and IL-3-induced activation molecule on eosinophils - PubMed (original) (raw)
CD48 is an allergen and IL-3-induced activation molecule on eosinophils
Ariel Munitz et al. J Immunol. 2006.
Abstract
Eosinophils are involved in a variety of allergic, parasitic, malignant, and idiopathic disorders by releasing a variety of factors including specific granule proteins, lipid mediators, and proinflammatory and immunoregulatory cytokines and chemokines. In addition, they interact with various cell types in the inflamed tissue. Yet, the mechanism of eosinophil activation is still poorly understood. Recently, we described the expression and function of the CD2-subfamily of receptors and especially 2B4 on human eosinophils. In this study we focus on CD48, the high-affinity ligand of 2B4. CD48 is a GPI-anchored protein involved in cellular activation, costimulation, and adhesion, but has not been studied on eosinophils. We demonstrate that human eosinophils from atopic asthmatics display enhanced levels of CD48 expression and that IL-3 up-regulates CD48 expression. Furthermore, cross-linking CD48 on human eosinophils triggers release of eosinophil granule proteins. Assessment of CD48 expression in a murine model of experimental asthma revealed that CD48 is induced by allergen challenge and partially regulated by IL-3. Additionally, anti-IL-3 reduces CD48 expression and the degree of airway inflammation. Thus, CD48 is an IL-3-induced activating receptor on eosinophils, likely involved in promoting allergic inflammation.
Similar articles
- The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation.
Minai-Fleminger Y, Gangwar RS, Migalovich-Sheikhet H, Seaf M, Leibovici V, Hollander N, Feld M, Moses AE, Homey B, Levi-Schaffer F. Minai-Fleminger Y, et al. Clin Exp Allergy. 2014 Nov;44(11):1335-46. doi: 10.1111/cea.12422. Clin Exp Allergy. 2014. PMID: 25255823 - 2B4 (CD244) is expressed and functional on human eosinophils.
Munitz A, Bachelet I, Fraenkel S, Katz G, Mandelboim O, Simon HU, Moretta L, Colonna M, Levi-Schaffer F. Munitz A, et al. J Immunol. 2005 Jan 1;174(1):110-8. doi: 10.4049/jimmunol.174.1.110. J Immunol. 2005. PMID: 15611233 - sCD48 is anti-inflammatory in Staphylococcus aureus Enterotoxin B-induced eosinophilic inflammation.
Gangwar RS, Levi-Schaffer F. Gangwar RS, et al. Allergy. 2016 Jun;71(6):829-39. doi: 10.1111/all.12851. Epub 2016 Feb 26. Allergy. 2016. PMID: 26836239 - CD48: A co-stimulatory receptor of immunity.
Elishmereni M, Levi-Schaffer F. Elishmereni M, et al. Int J Biochem Cell Biol. 2011 Jan;43(1):25-8. doi: 10.1016/j.biocel.2010.09.001. Epub 2010 Sep 15. Int J Biochem Cell Biol. 2011. PMID: 20833258 Review. - CD48 as a novel target in asthma therapy.
Munitz A, Bachelet I, Levi-Schaffer F. Munitz A, et al. Recent Pat Inflamm Allergy Drug Discov. 2007 Feb;1(1):9-12. doi: 10.2174/187221307779815057. Recent Pat Inflamm Allergy Drug Discov. 2007. PMID: 19075961 Review.
Cited by
- Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy.
Grisaru-Tal S, Rothenberg ME, Munitz A. Grisaru-Tal S, et al. Nat Immunol. 2022 Sep;23(9):1309-1316. doi: 10.1038/s41590-022-01291-2. Epub 2022 Aug 24. Nat Immunol. 2022. PMID: 36002647 Free PMC article. Review. - Latest Progresses in Allergic Diseases Biomarkers: Asthma and Atopic Dermatitis.
Puzzovio PG, Levi-Schaffer F. Puzzovio PG, et al. Front Pharmacol. 2021 Sep 30;12:747364. doi: 10.3389/fphar.2021.747364. eCollection 2021. Front Pharmacol. 2021. PMID: 34658882 Free PMC article. Review. - CD48 Expression on Eosinophils in Nasal Polyps of Chronic Rhinosinusitis Patients.
Zoabi Y, Rahimli Alekberli F, Minai-Fleminger Y, Eliashar R, Levi-Schaffer F. Zoabi Y, et al. Int Arch Allergy Immunol. 2021;182(10):962-970. doi: 10.1159/000515918. Epub 2021 Apr 28. Int Arch Allergy Immunol. 2021. PMID: 33910197 Free PMC article. - Evaluation of Soluble CD48 Levels in Patients with Allergic and Nonallergic Asthma in Relation to Markers of Type 2 and Non-Type 2 Immunity: An Observational Study.
Breuer O, Gangwar RS, Seaf M, Barhoum A, Kerem E, Levi-Schaffer F. Breuer O, et al. J Immunol Res. 2018 Sep 16;2018:4236263. doi: 10.1155/2018/4236263. eCollection 2018. J Immunol Res. 2018. PMID: 30306094 Free PMC article. - Eosinophil Activation Status in Separate Compartments and Association with Asthma.
Johansson MW. Johansson MW. Front Med (Lausanne). 2017 Jun 12;4:75. doi: 10.3389/fmed.2017.00075. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28660189 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous